Ambrogi Michael J. 4

Accession 0001645113-20-000101

CIK 0001645113other

View on SEC.gov Company Profile

Filed

Jul 22, 8:00 PM ET

Accepted

Jul 23, 7:43 PM ET

Size

44.7 KB

Accession

0001645113-20-000101

Insider Transaction Report

Form 4

Period: 2020-07-21

NovoCure LtdNVCR

Ambrogi Michael J.

Chief Operating Officer

Transactions

Exercise/Conversion
Options to Buy Ordinary Shares
2020-07-22−8,426→ 0 total
Exercise: $11.46Exp: 2026-02-24→ Ordinary Shares (8,426 underlying)
Exercise/Conversion
Options to Buy Ordinary Shares
2020-07-22−30,772→ 67,586 total
Exercise: $21.15Exp: 2028-02-26→ Ordinary Shares (30,772 underlying)
Exercise/Conversion
Options to Buy Ordinary Shares
2020-07-21−3,021→ 98,358 total
Exercise: $21.15Exp: 2028-02-26→ Ordinary Shares (3,021 underlying)
Exercise/Conversion
Ordinary Shares
2020-07-21$21.15/sh+3,021$63,894→ 223,888 total
Exercise/Conversion
Ordinary Shares
2020-07-22$11.46/sh+8,426$96,562→ 229,293 total
Sale
Ordinary Shares
2020-07-22$65.53/sh−400$26,210→ 228,893 total
Exercise/Conversion
Ordinary Shares
2020-07-22$11.46/sh+3,774$43,250→ 224,641 total
Sale
Ordinary Shares
2020-07-22$67.39/sh−17,175$1,157,475→ 220,867 total
Exercise/Conversion
Ordinary Shares
2020-07-21$11.46/sh+300$3,438→ 221,167 total
Sale
Ordinary Shares
2020-07-22$66.77/sh−4,228$282,287→ 224,665 total
Sale
Ordinary Shares
2020-07-22$67.48/sh−3,798$256,274→ 220,867 total
Sale
Ordinary Shares
2020-07-22$66.50/sh−1,151$76,539→ 223,490 total
Sale
Ordinary Shares
2020-07-22$67.28/sh−2,623$176,470→ 220,867 total
Sale
Ordinary Shares
2020-07-22$65.49/sh−1,380$90,375→ 250,259 total
Sale
Ordinary Shares
2020-07-22$66.66/sh−12,217$814,336→ 238,042 total
Exercise/Conversion
Options to Buy Ordinary Shares
2020-07-21−300→ 8,426 total
Exercise: $11.46Exp: 2026-02-24→ Ordinary Shares (300 underlying)
Sale
Ordinary Shares
2020-07-21$65.07/sh−300$19,520→ 220,867 total
Sale
Ordinary Shares
2020-07-21$65.06/sh−3,021$196,552→ 220,867 total
Exercise/Conversion
Ordinary Shares
2020-07-22$21.15/sh+30,772$650,828→ 251,639 total
Exercise/Conversion
Options to Buy Ordinary Shares
2020-07-22−3,774→ 0 total
Exercise: $11.46Exp: 2026-02-24→ Ordinary Shares (3,774 underlying)

Footnotes (13)

[F1]On July 21, 2020, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 300 shares in multiple trades at prices ranging from $65.00 to $65.11. The price reported above reflects the weighted average sale price. Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.
[F10]On July 22, 2020, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 17,175 shares in multiple trades at prices ranging from $67.04 to $67.94. The price reported above reflects the weighted average sale price. Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.
[F11]Fully vested as of the date hereof.
[F12]Fully-vested as of the date hereof except for options to purchase 67,586 ordinary shares, which will vest in equal installments on each of 2/26/21 and 2/26/22, subject to the reporting person's continued employment through such dates.
[F13]Options to purchase 67,586 ordinary shares will vest and become exercisable in equal installments on each of 2/26/21 and 2/26/22, subject to the reporting person's continued employment through such dates.
[F2]On July 21, 2020, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 3,021 shares in multiple trades at prices ranging from $65.00 to $65.31. The price reported above reflects the weighted average sale price. Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.
[F3]On July 22, 2020, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 400 shares in multiple trades at prices ranging from $65.16 to $65.82. The price reported above reflects the weighted average sale price. Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.
[F4]On July 22, 2020, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 4,228 shares in multiple trades at prices ranging from $66.21 to $67.19. The price reported above reflects the weighted average sale price. Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.
[F5]On July 22, 2020, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 3,798 shares in multiple trades at prices ranging from $67.21 to $67.80. The price reported above reflects the weighted average sale price. Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.
[F6]On July 21, 2020, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 1,151 shares in multiple trades at prices ranging from $65.76 to $66.75. The price reported above reflects the weighted average sale price. Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.
[F7]On July 22, 2020, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 2,623 shares in multiple trades at prices ranging from $66.79 to $67.64. The price reported above reflects the weighted average sale price. Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.
[F8]On July 22, 2020, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 1,380 shares in multiple trades at prices ranging from $65.00 to $65.92. The price reported above reflects the weighted average sale price. Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.
[F9]On July 22, 2020, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 12,217 shares in multiple trades at prices ranging from $66.03 to $67.02. The price reported above reflects the weighted average sale price. Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.

Documents

2 files

Issuer

NovoCure Ltd

CIK 0001645113

→

Entity typeother

Related Parties

filerCIK 0001654363

Filing Metadata

Form type: 4
Filed: Jul 22, 8:00 PM ET
Accepted: Jul 23, 7:43 PM ET
Size: 44.7 KB

View on SEC.gov